医学
气胸
外科
胸导管
胸腔镜检查
电视胸腔镜手术
入射(几何)
胸膜成形术
队列
内科学
光学
物理
作者
Giuseppe Cardillo,Oliver Bintcliffe,Francesco Carleo,Luigi Carbone,Marco Martino,Brennan C Kahan,Nick Maskell
出处
期刊:Thorax
[BMJ]
日期:2016-07-15
卷期号:71 (9): 847-853
被引量:57
标识
DOI:10.1136/thoraxjnl-2015-207976
摘要
Background
Video-assisted thoracoscopic surgery (VATS) is an increasingly common treatment for recurrent or persistent primary spontaneous pneumothorax (PSP). Surgery usually involves diffuse treatment of the pleura and possible targeted therapy to areas of bullous disease. The purpose of this large cohort study was to examine incidence of recurrence after VATS and identify predictors of outcome. Methods
Patients undergoing VATS for PSP at a single centre between 2000 and 2012 were prospectively enrolled. All patients underwent talc poudrage. Targeted surgical techniques were used based on presence of air leak and Vanderschueren9s stage. Patients had clinical and radiological follow-up for at least 2 years (median 8.5 years). Results
1415 patients with PSP underwent VATS with talc poudrage. The most frequent indications were recurrent pneumothorax (92.2%) and persistent air leak (6.5%). The complication rate was 2.0% of which 1.7% was prolonged air leak. There was no mortality. Median length of stay was 5 days. Recurrent pneumothorax occurred in 26 patients (1.9%). At the time of surgery, 592 patients smoked (43%) and they had a significantly higher incidence of recurrence (24/575, 4.2%) than non-smokers (2/805, 0.2%), p<0.001. The incidence of recurrence in those undergoing bullae suturing (3.8%, n=260) was significant higher than those undergoing poudrage alone (0.3%, p=0.036). Conclusion
The marked difference in recurrence between smokers and non-smokers suggests this as an important predictor of outcome. This study demonstrates a low incidence of recurrence and complications for patients with PSP undergoing VATS with talc poudrage. Talc poudrage requires prospective comparison with pleurectomy and mechanical abrasion.
科研通智能强力驱动
Strongly Powered by AbleSci AI